621 filings
Page 8 of 32
10-Q
2021 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 May 21
12:00am
4
Gerald J McDougall
13 May 21
NeuBase Therapeutics / Gerald J McDougall ownership change
6:03pm
3
Gerald J McDougall
13 May 21
NeuBase Therapeutics / Gerald J McDougall ownership change
6:02pm
8-K
NBSE
NeuBase Therapeutics Inc
13 May 21
NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021
4:32pm
8-K
NBSE
NeuBase Therapeutics Inc
12 May 21
NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors
4:30pm
8-K
NBSE
NeuBase Therapeutics Inc
30 Apr 21
Other Events
5:01pm
4
NBSE
NeuBase Therapeutics Inc
27 Apr 21
NeuBase Therapeutics / ERIC I RICHMAN ownership change
4:03pm
4
Stephan Dietrich A
27 Apr 21
NeuBase Therapeutics / Dietrich A Stephan ownership change
4:03pm
4
NBSE
NeuBase Therapeutics Inc
27 Apr 21
NeuBase Therapeutics / DOV A MD GOLDSTEIN ownership change
4:02pm
4
NBSE
NeuBase Therapeutics Inc
27 Apr 21
NeuBase Therapeutics / William Roland Mann ownership change
4:01pm
8-K
NBSE
NeuBase Therapeutics Inc
27 Apr 21
Entry into a Material Definitive Agreement
7:30am
8-K
NBSE
NeuBase Therapeutics Inc
26 Apr 21
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:11pm
424B5
NBSE
NeuBase Therapeutics Inc
23 Apr 21
Prospectus supplement for primary offering
4:05pm
8-K
NBSE
NeuBase Therapeutics Inc
22 Apr 21
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
9:33am
424B5
NBSE
NeuBase Therapeutics Inc
21 Apr 21
Prospectus supplement for primary offering
4:03pm
EFFECT
NBSE
NeuBase Therapeutics Inc
15 Apr 21
Notice of effectiveness
12:15am
CORRESP
NBSE
NeuBase Therapeutics Inc
12 Apr 21
Correspondence with SEC
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
8 Apr 21
Letter from SEC
12:00am
S-3
NBSE
NeuBase Therapeutics Inc
Shelf registration
1 Apr 21
5:21pm
8-K
NBSE
NeuBase Therapeutics Inc
26 Mar 21
Departure of Directors or Certain Officers
5:02pm